FDA Panel Calls for Reclassification of Testosterone, Expanding Access for Men with Low Hormone Levels
On Wednesday, a 13‑member FDA panel urged the agency to strip testosterone of its…
On Wednesday, a 13‑member FDA panel urged the agency to strip testosterone of its…